1 / 10

Algunos proyectos 2004

Mia_John
Download Presentation

Algunos proyectos 2004

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Confidential Algunos proyectos 2004

    2. Confidential

    3. Confidential New product evaluation in Rheumatoid arthritis for German market (Dec-04) Rheumatoid disease pag.7: Epidemiology Management Treatment guidelines NSAIDs Future competitors NSAIDs qualitative analysis pag. 22: Indications Efficacy Profile comparison Side Effects profile pag. 41 NSAIDs vs COX2 NSAIDs overview in Germany pag.69: Molecules, Indications, Prices & reimbursement Anti-rheumatics market analysis in Germany pag.76: Market profile SW Positioning map Quantitative analysis in units & values Promotional investments Prescribers analysis: Target Size & Segmentation Product X profile pag.92: SPC profile & international position Scientific profile SWOT Sales forecast pag.112 P&L account

    4. Confidential Re-launch plan for a CNS product (Nov-04) Market analysis Part I: Past & Present Market Size & Evolution in units Molecules in units Prices evolution Market Size & Evolution in Values Molecules in values Market Segments Prescriptions & Prescribers analysis Product X: Past & Present Market analysis Part II: Future & Forecasting Forecast in units Prices estimations Forecast in values Marketing Plan 2005: SWOT analysis Positioning Key messages Qualitative objectives Strategies Marketing Activities Promotional plan Quantitative objectives: Sales forecast

    5. Confidential Potential evaluation for off-label indications in a CNS drug (Oct-04) Market segmentation. Identification of potential new segments for the drug. Deep analysis of each new potential indication: Therapeutical treatment and needs Scientific potential of our drug Economical potential Business plan for selected new indications: SWOT, Positioning, Objectives, Strategies Action plan in new indications off-label

    6. Confidential Business Plan CNS drug (Sept-04) Product Analysis in 2004 Sales evolution: IMS, Internal & Comparison Success based on 2004 objectives, strategies & promotion Conclusions Market analysis: Part I: Qualitative Analysis indication 1 Part II: Quantitative Analysis & market forecasting in indication 1 Part III: Qualitative Analysis off-label indications Part IV: Quantitative Analysis & market forecasting in off-label indications Marketing Plan for 2005: SWOT analysis Product positioning by indications Key messages by indication Objectives 2005: Qualitative objectives by indication Strategies Action plan Quantitative Objectives, Sales Forecast & Promotional Plan Conclusions

    7. Confidential Evaluation and Business case for a new therapeutical concept in CV (Sep-04) Pathology overview (HF, PAD) Epidemiology Current treatment guidelines Unmet needs Product profile Summary: Scientific evaluation of the product profile Phase II results analysis in each indication Phase III results analysis Comparison with treatment alternatives (current & future) Barriers and opportunities of this new therapeutical concept Market analysis Size & evolution Market Segmentation Prescriptions & Prescribers analysis Patients estimation Product sales potential estimation in each indication: 10 years sales potential in Spain, Greece, Portugal, France, Italy, Germany & Benelux 10 years P&L in Spain, Greece, Portugal, France, Italy, Germany & Benelux

    8. Confidential Business plan for a new JV (Jun-04) New business definition: Description Objectives Strategies Market analysis: Market review in therapeutical area Selection of potential portfolio Sales potential estimation Promotional plan: Definition of target Needs of sales force Promotional strategy Structure and organization of new company Investments plan for 10 years P&L account for 10 years Cash-flow plan

    9. Confidential Evaluation and Business case for a new treatment in CV (May-04) Pathology overview Indication 1 & Indication 2: Epidemiology and evolution Current treatment guidelines Real treatment habits Market analysis: Market definition Market potential: indication 1 & indication 2 Competitors SW Prescriptions analysis Product X profile: Scientific evidence in indication 1 Scientific evidence in indication 2 Evidence in combination with therapeutical group Y Conclusions On-going trials Marketing plan: SWOT analysis Positioning in indication 1 & 2 Key messages in indication 1 & 2 Qualitative objectives Quantitative objectives: 10 years sales & patients forecast in indication 1 & 2 Key strategies & activities Target definition Promotional strategy Promotional plan Investments plan P&L account (10 years)

    10. Confidential Initial evaluation of potential for a new product in pancreatic cancer (Apr-04) Pancreatic cancer: Epidemiology Treatment options Treatments under development Clinical trials on-going in Pancreatic cancer Product X: Profile Results Therapeutical group back-ground Other developments Key conclusions / items to clarify Preliminary market potential estimation for Spain

More Related